NGS reads files of PSCCE
The aligned bam file of next generation sequencing performed on PSCCE.
- 64 samples
- DAC: EGAC00001001857
- Technology: Illumina NovaSeq 6000
- HMB DUO:0000006 (version: 2019-01-07)health or medical or biomedical researchThis data use permission indicates that use is allowed for health/medical/biomedical purposes; does not include the study of population origins or ancestry.
- PUB DUO:0000019 (version: 2019-01-07)publication requiredThis data use modifier indicates that requestor agrees to make results of studies using the data available to the larger scientific community.
- US DUO:0000026 (version: 2019-01-07)user specific restrictionThis data use modifier indicates that use is limited to use by approved users.
- PS DUO:0000027 (version: 2019-01-07)project specific restrictionThis data use modifier indicates that use is limited to use within an approved project.
- IS DUO:0000028 (version: 2019-01-07)institution specific restrictionThis data use modifier indicates that use is limited to use within an approved institution.
Data access policy of PSCCE study
Data Access Agreement Version 1.2.20210502 This Data Access Agreement governs the terms of access to controlled datasets generated by Department of Thoracic Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences. In signing this agreement, you agree to be bound by the terms and conditions of access set out therein. Definitions Data Provider: Department of Thoracic Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences. Data: ______________________________________(please type in the Study/Dataset/Data title and ID for the Data applied) User: An applicant, having signed this Data Access Agreement, whose User Institution has cosigned this Data Access Agreement, both of them having received acknowledgement of its acceptance. Any person listed as a co-author of the papers or publications using the Data would be considered a User and should sign this Data Access Agreement. User Institution: Institution at which the User is employed, affiliated or enrolled. A representative of it has co-signed this Data Access Agreement with the User and received acknowledgement of its acceptance. Research Participant: An individual having contributed their personal data and human genetic resource to generate the Data. Terms and Conditions In signing this Data Access Agreement: 1. The User and the User Institution accept that the Data is protected by and subject to international laws, including but not limited to Biosecurity Law of the People’s Republic of China and the People’s Republic of China Regulations on Human Genetic Resources. The Data Provider reserves the right to request and inspect data security and management documentation to ensure the adequacy of data protection measures. 2. The User and the User Institution agree to use the Data only for the advancement of medical research. And not to use the Data for the creation of products for sales or for any commercial purpose. 3. The User and the User Institution agree to preserve, at all times, the confidentiality of the information and Data. In particular, they undertake not to use, or attempt to use the Data to compromise or otherwise infringe the confidentiality of information on research participants. 4. The User and the User Institution agree to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 5. The User and the User Institution agree not to pursue any research with the goal to identify Research Participants and not to link or combine the Data to other information or archived data in a way that would co-identify the Research Participants, even if access to the data has been formally granted to the User and the User Institution, or is freely available without restriction. 6. The User and the User Institution agree not to transfer, distribute or disclose the Data, in whole or part, or any material derived from the Data to anyone not listed in the Data Access Agreement. 7. The User and the User Institution accept that the Data Provider bears no legal responsibility for the accuracy or comprehensiveness of the Data. 8. The User and the User Institution accept that the Data Provider accepts no liability for indirect, consequential, or incidental, damages or losses arising from use of the Data. 9. The User and the User Institution agree not to make intellectual property claims on the Data and not to use intellectual property protection in ways that would prevent or block access to any element of the Data. 10. The User and the User Institution will notify the Data Provider and the Data Access Committee as soon as they become aware of a breach of the terms and conditions of this agreement. 11. This agreement shall be effective as of the date of the last party to sign below (“Effective Date”) and shall terminate two (2) years after the Effective Date, unless terminated sooner pursuant to Section 12 below. 12. The User and the User Institution accept that this Data Access Agreement may terminate immediately upon any breach of this agreement from the User and the User Institution. Either Party may terminate this Data Access Agreement upon thirty (30) days written notice for any reason. 13. In the case of Section 11 and 12, the User and the User Institution agree to destroy any Data held, including copies and backup copies. 14. The User and the User Institution agree to destroy any Data held, once it is no longer used for approved purpose. 15. The following Sections of this Data Access Agreement shall survive its expiration or termination: Sections 1-10, Sections 13-14. 16. This Data Access Agreement shall be constructed, interpreted and governed by the laws of People’s Republic of China and shall be subject to the non-exclusive jurisdiction of the courts of People’s Republic of China. For and on behalf of National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences Signature of institutional representative _______________ Print name of institutional representative _______________ Date _______________ Stamp For and on behalf of the User Print name of all User(s): _______________ _______________ _______________ _______________ _______________ _______________ Signatures of all User(s): _______________ _______________ _______________ _______________ _______________ _______________ Date _______________ For and on behalf of the User Institution Name of the User Institution _______________ Signature of institutional representative _______________ Print name of institutional representative _______________ Date _______________ Stamp
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
Study ID | Study Title | Study Type |
---|---|---|
EGAS00001004889 | Other |
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.